Approved Study Database

Ref. No. Scientific Title Principal investigator
2013.628 Predictors of women’s preference for non-medically indicated cesarean section Prof. Ip Wan Yim
2020.083 Retrospective Review on the Compliance of Renal Dose Adjustment of Alogliptin switched from Linagliptin in Patients with Type 2 Diabetes Mellitus Miss IP Rosanna Yan Yu
葉忻渝
2020.110 Prospective study on clinical outcomes of women who suffered from Mayer-Rokitansky-Kuster-Hauser Syndrome Dr. IP Patricia Nga Ping
葉雅平
2019.109 Use of Buscopan in patients undergoing IVF/ICSI treatment with high and low uterine contraction frequency prior to embryo transfer: A prospective double-blinded randomized controlled trial Dr. IP Patricia Nga Ping
2010.550 The efficacy and safety of combination therapy of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) in patient with proteinuria previously treated with monotherapy of ACE inhibitor / ARB in a local hospital Mr Ip Ngai Chun
2008.297 Comparative Activity of Carbapenem Testing Etest Study (COMPACT) Dr. Ip Margaret
2012.054 Clinical Outcome of Streptococcus agalactiae or group B streptococcus (GBS) Basteremia and Invasive Diseases among Adults in Hong Kong Prof Ip Margaret
2010.389 Multi-center evaluation of the burden of invasive neonatal group B streptococcal disease: Incidence and Serotype Distribution Prof Ip Margaret
2012.049 A three year review on Serotypes and In-vitro Antibiotic Susceptibilitics of Streptococcus pneumoniae from Hospitalized Adult Pateitns in a Hong Kong Hospital, 2009-2011 Prof Ip Margaret
2009.068 Clinical and Economic Impact of Nosocomial Acinetobacter Baumannii Bacteremia Prof Ip Margaret
2013.452 The Evaluation of Computer Aided Pathology Diagnosis system for Tuberculosis Sputum Smear. Prof Ip Margaret
2019.545 Study for Monitoring Antimicrobial Resistance Trends (SMART) Prof. IP Margaret
2020.561 A retrospective review of pneumococcal disease and other respiratory infection in Hong Kong hospitals Prof. IP Margaret
葉碧瑤
2019.013 Surveillance of bacterial pathogens by whole-genome sequencing Prof. IP Margaret
葉碧瑤
2018.116 Modulation of gut microbiota with probiotics: a pilot study Prof. IP Margaret
葉碧瑤
2018.261 Isolation of CD34 stem cells from cord blood Prof. IP Margaret
叶碧瑶
2020.608 Surveillance of Streptococcus pneumoniae and respiratory viruses in children hospitalised for acute respiratory illnesses in Hong Kong (2017-2019) to assess the ongoing impact of pneumococcal conjugate vaccines Prof. IP Margaret
2019.657 Burden of Streptococcus agalactiae (GBS) disease in Hong Kong Prof. IP Margaret
葉碧瑤
2018.628 Resistome of gut microbiota and modulation in healthy Hong Kong population Prof. IP Margaret
葉碧瑤
2020.007 One Health approach to Track and Target Antimicrobial Resistance (TnT-AMR) Prof. IP Margaret
葉碧瑤
2018.509 A review on infections and colonization of Streptococcus agalactiae in Hong Kong, 2007-2021 Prof. IP Margaret
2023.072 Sealing the gaps: Lactobacillus spp. mediated mitigation of insulin resistance-induced intestinal epithelium dysfunction and modulation of carbapenem resistant Klebsiella pneumoniae infection in an in vivo model Prof. IP Margaret
2022.473 Enhanced surveillance of sepsis through application of rapid diagnostics and molecular typing tools Prof. IP Margaret
葉碧瑤
2022.058 Decolonization of carbapenemase-producing Enterobacteriaceae through modulation of the gut microbiota and its resistome Prof. IP Margaret
葉碧瑤
2021.041 Burden of streptococcal infection and colonization in Hong Kong Prof. IP Margaret
葉碧瑤
2023.122 A Belt and Road platform to track and tackle MRSA disease and carriage, elucidating their antimicrobial and biocide resistance, genetic diversity and transmission dynamics between humans, animals and the environment Prof. IP Margaret
2023.071 Epidemiology of Klebsiella pneumoniae by whole-genome sequencing Prof. IP Margaret
2017.230 Dissecting human and animal Streptococcus agalactiae (Group B streptococcus) and its resistance determinants through territory-wide sampling Prof. IP Margaret
2016.043 Epidemiology and Detection of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hong Kong hospitals Prof. IP Margaret
葉碧瑤
2014.403 Impact of macrolide non susceptibility in Mycoplasma pneumoniae on childhood respiratory diseases Prof Ip Margaret
2015.519 A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2012 - 2014. Prof. IP Margaret
葉碧瑤
2016.228 Antibiotic Susceptibility testing of Temocillin and other agents against Enterobacteriaceae in Hong Kong. Prof IP Margaret
葉碧瑤
2017.448 A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2015 - 2016. Prof. IP Margaret
2017.152 Whole Genome Sequencing-based characterization of Carbapenem-resistant Enterobacteriaceae in Hong Kong Prof. IP Margaret
2014.306 Combating Vancomycin-Resistant Enterococci (VRE) with antibiotics with active ingredients from Traditional Chinese Medicine (TCM) Prof. IP Margaret
2008.030 Factors Affecting Clinical Outcomes of Vancomyic Therapy for Methicillin-Resistant Staphylococcus Aureus Bactgeraemia Dr Ip Margaret
2010.305 Evaluation of a nurse-led Comprehensive Child Development Service Program for high risk pregnant women in Hong Kong Ms Ip Lai Sheung
2008.494 Compare the Clinical Outcomes of Non-operative Versus Operative Treatment in Mason Type II Radial Head Fracture, Restrospective Study DR IP Kai Yuen
2014.625 The prevalence and risk factors associated with the use of Potentially Inappropriate Medication in Old Age Homes and Prince of Wales Hospital - a retrospective cohort study Student Ip Kai Cheung
2024.329 Mindfulness Intervention for Reducing Stress and Anxiety in Postnatal Women: A Six-Week Program Dr IP KA HIM
2024.209 Molecular Characterization of CDKL5 Deficiency Disorders (CDD) with Human Brain Samples Prof. IP Jacque Pak Kan
2022.290 A Fifteen-year Retrospective Review on Livedoid Vasculopathy in a Tertiary Centre Dr. IP Edric Chi Ching
2021.028 A pilot randomized controlled trial of integrative Motivational Interviewing and Contingency Management program (MICM) for dual-diagnosed patients to enhance psychiatric medication adherence Mr. IP Chi Kin
葉志堅
2017.381 The feasibility study over the outcomes of substance abusers in residential detox centers when compared with video medical consultation verus face-to-face consultation Mr. IP Chi Kin
葉志堅
2020.383 Effect of Acceptance and Commitment Therapy-based lifestyle counselling programme for people with early psychosis on physical activity: a pilot randomized controlled trial Mr. IP Chi Kin
葉志堅
2021.627 Comparative efficacy and safety of treatments in Intracerebral Bleeding during Direct Oral Anticoagulant Usage – a population-based study Dr. IP Bonaventure Yiu Ming
葉耀明
2021.386 Impact of COVID-19 Vaccines on Cerebrovascular Health – a community-based study Dr. IP Bonaventure Yiu Ming
2023.602 Precision Research Integrating Multiomics, Gut Microbiome and Advanced Imaging Assessment for Stroke, Neuroinflammatory and Neurodegenerative Diseases – PRIMMA Consortium Dr. IP Bonaventure Yiu Ming
2022.639 Epidemiological Update on Migraine in Hong Kong Dr. IP Bonaventure Yiu Ming
葉耀明
2022.008 Colchicine Use in Intracranial Atherosclerotic Disease – a pilot open-labelled randomized trial Dr. IP Bonaventure Yiu Ming
葉耀明

Page 157 of 265.